Tenofovir is associated with lower risk of hepatocellular carcinoma than entecavir in patients with chronic HBV infection in China

TCF Yip, VWS Wong, HLY Chan, YK Tse, GCY Lui… - Gastroenterology, 2020 - Elsevier
Background & Aims There have been conflicting results from studies comparing the risk of
hepatocellular carcinoma (HCC) in patients with chronic hepatitis B virus (HBV) infection …
被引用次数：202 相关文章

Tenofovir Is Associated With Lower Risk of Hepatocellular Carcinoma Than Entecavir in Patients With Chronic HBV Infection in China.

TC Yip, VW Wong, HL Chan, YK Tse, GC Lui… - …, 2019 - europepmc.org
Methods We performed a retrospective study of consecutive adults with chronic HBV
infection who initially received treatment with entecavir or TDF, for at least 6 months, from …

Tenofovir Is Associated With Lower Risk of Hepatocellular Carcinoma Than Entecavir in Patients With Chronic HBV Infection in China

TCF Yip, VWS Wong, HLY Chan, YK Tse… - …, 2020 - gastrojournal.org
Background & Aims There have been conflicting results from studies comparing the risk of
hepatocellular carcinoma (HCC) in patients with chronic hepatitis B virus (HBV) infection …

[引用][C] Tenofovir Is Associated With Lower Risk of Hepatocellular Carcinoma Than Entecavir in Patients With Chronic HBV Infection in China

TCF Yip, VWS Wong, HLY Chan, YK Tse, GCY Lui… - Gastroenterology, 2020 - cir.nii.ac.jp
Tenofovir Is Associated With Lower Risk of Hepatocellular Carcinoma Than Entecavir in
Patients With Chronic HBV Infection in China | CiNii Research CiNii 国立情報学研究所 学術 …

Tenofovir Is Associated With Lower Risk of Hepatocellular Carcinoma Than Entecavir in Patients With Chronic HBV Infection in China

TCF Yip, VWS Wong, HLY Chan, YK Tse… - …, 2020 - pubmed.ncbi.nlm.nih.gov
Background & aims There have been conflicting results from studies comparing the risk of
hepatocellular carcinoma (HCC) in patients with chronic hepatitis B virus (HBV) infection …

Tenofovir is associated with lower risk of hepatocellular carcinoma than entecavir in patients with chronic HBV infection in China.

TCF Yip, VWS Wong, HLY Chan, YK Tse, GCY Lui… - 2020 - cabidigitallibrary.org
Abstract Background & Aims: There have been conflicting results from studies comparing the
risk of hepatocellular carcinoma (HCC) in patients with chronic hepatitis B virus (HBV) …